@IndianEnergyXch
Transformation drivers
1) Decarbonization - use of solar & wind ,RE (renewable energy)
2) Decentralisation - RE a threat to centralized energy productn
3) Digitization
4) Democratization- peer 2 peer energy trading
Changing energy mix
2020/ 2022 /2030 % of contribution
Thermal 62 /53 /35
Wind 10 /12 /17
Solar 9 / 20/ 36
Hydro 12 / 10 /8

Electricity value chain 4 parts
Generation - Transmission - Distribution - Consumption

Power sector construct
Long term 90%
Short term 10%
Power markets in developed countries are in range 30 - 80% of total power demand ,India 5%

Share of exchange in total generation
2016 - 2.9 %
2021 - 5.2%
Share of ST market in total generation
2016 - 9.9%
2021 - 10.3%
Exchange mkt & ST MKT as % of total gen
2016 29.9
2021 50.2
Electricity consumption to increase
Per capita consumption India 1/3rd global avg,to double over 5 yrs
- Core sector growth ,industrializationrapid urbanization to drive demand
Last mile connectivity- Saubhagya ,power for all 24/7
Demand
2017 - 1236 BU
2020 - 1381 BU

#stocks
Per capita electricity consumptn (KWh)
US 12994
Brazil 2601
China 3927
Global avg 3127
India 1181

IEX India leading power Xchange platform,mkt share 95%
Avg daily trade 6000+ MW
Record day vol 308 MUs

Customer
Industries 4000+
Discoms 55+
ES Cert 100+
Generators 500+
REs 1500+
#IEX Benefits
Benchmark prices for all electricity transactions
Transparent mech for price discovery
High liquidity on Xchnage ensure low cost,assured supply
One grid one price
Lower cost for discoms end users
Flexibility on 15 min basis
Market segments
Day ahead mkt ,Intraday ,Term ahead 11 days, RE certification, ES Cert ,Real time within an hour

India signatory to Paris agreement 2016
40% RE by 2030
450 GW installed RE capacity
Consumer demand for green energy
New Green term ahead mkt,launched Aug 2020
Real time market segment
Launched Jun 20
48 bid sessions intraday,15 min each starting 22.45, anonymous bidding
Benefit - manage demand supply ,generators can sell excess/surplus capacity ,Enable grid operators to enhance safety/ security of grid
New launches
Cross border trade ,green day ahead mkt, longer duration contract ,banking contracts ,gas exchange
Maharashtra discoms turned to Xchanges ,shunned costly PPAs in Apr 2020

IEX transaction vols up 4x 2011 to 20
India electricity mkt dominated by Longterm PPA ~90%
Need for ST Mkt currently 10% driven by supply issues,price arbitrage opportunity, load variance
Gradual shift toward ST mkt

Energy xchange platforms
IEX 95 % share
PXIL of NSE 5%
97% contracts of daily traded vols in Day ahead mkt (DAM) & Term ahead Mkt (TAM) pass thru IEX
Low cost operating structure
90% income from transaction fees INR 0.04/kwh/transaction
10% from admission & membership fees

Risk to IEX model :
Lower transaction fee
New players
Stagnant mkt share
Change in Xchnage platform design

@IndianEnergyXch
Unroll
@threadreaderapp
@IndianEnergyXch
Mkt share of 95%/40% of spot/short term power mkt
Shift of vols to power exchanges & new products to aid growth
Better price discovery, transparent pricing,RE ,low transmission congestion to shift momentum to Spot mkt
Zero debt,efficient cash conversion,80% GMs

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with TheMarket🐝

TheMarket🐝 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @BullsforBears

24 Dec
#Dixon key beneficiary of GOI PLI scheme
Through its subsidiary Padget electronics, Dixon made 2 applications for phones costing < 15000 ,70% India mobile mkt share
Incentive of 4 to 6% under PLI subject to a cap
Total investment 200crs ,50 cr/yr till 2025
#dixontechnologies
Post expansion revenue share of mobiles to jump to 44 from 12% currently
Ramp up capacity from 3 mn today to 15-16 mn over next few yrs ,aim for revenue 28-30000 crs over next 5 yrs
In talks 3 large players

Set top boxes, delivered 5.2 lakh to jio,dish,Citi
Order book 0.3mn/mon
Dixon is both OEM Player & ODM ( original design manufacturer)
Expanding capacities in Android & Linux TV ,semi automatic and top load washing machines
Current capacity 4 mn TV sets ,30%LED Mkt,acquired new customers Samsung,Nokia,Ramos capacity to 5.5 mn
#Nifty #stocks
Read 6 tweets
23 Dec
@JubilantLifeSci
Q2fy21 Revenue up 4.8% yoy to 2347.9 crs led by traction in CMO/Generics in Pharma & Life sciences in LSI segment
- Radiopharma business impacted by Covid & launch of macroaggregated Albumin (MAA) by competitor Curium(jubilant was sole player)
#pharma #Nifty
MAA business witnessed price & mkt share erosion
-DTPA business impacted by decrease in ventilation scan due to covid
-Generic business growth led by traction existing products,launch of Remdesivir
-JLS to launch Remdesivir in 70 countries, exported API to US & injs in India
Radiopharma 90% & allergy business 100% precovid levels
-Partnership with SOFIE Biosciences in molecular theranostics
- JLS to double DDDS capacity by Fy22
- LSI business speciality declined 2% & nutritional grew 11% led by VIT D exports to EU while ethyl acetate muted growth
Read 4 tweets
22 Dec
@GranulesIndia
Q2fy21
Revenue up 22.7% to 858 crs
Formulations up 22.4% yoy 430 crs
API up 17% to 255
PFI up 32.6% to 173 crs
Vizag unit V commissioned for API ,oncology segment,
Company plans gradual shift from commoditized API to more complex drugs/ Formulations
#stocks
Company expects to commission MUPS block by Q3fy22
- Revenue contribution of core mols dropped to 70 from 80-85% end of Fy20
- #granules has 32 ANDA approved ,expect to launch 6 of these in Fy21
- Revised PAT guidance to 30% post Fy21 from 25% earlier
#StockMarket #Nifty
Company plans 7-9 product filings/year, atleast 5 for the US market
- Top 5 mols contributed 70%
- Capex guidance of 3.5 to 4 bn for fy21 & 3bn for Fy22
- Relaunch Metformin 750 mg in US over next year
- EU sales 23 % expected to reach 28% by Fy23, US sales to decline to 43%
Read 7 tweets
12 Dec
#amberenterprises Q2fy21 concall transcript

Q2 went well for Room AC industry,uptick retail demand, pent up demand
Overall electronic & consumer durables witnessed a good quarter
Inventory levels back to normal
Anticipate better H2fy21
#stock #StocksToWatch #Nifty #sensex
GOI banned import of refrigerant fill ACs, approx 30% of fully built RACs were imported mkt size 4000 crs , atmanirbhar bharat initiative,oppurtunity for domestic RAC players
Not easy for OEMs to import non-refrigerant fill ACs,unpack,gas fill test,negates cost advantage
#amberenterprises completed QIP 400 cr in Q2fy21, money used for debt repayment,capex,WC ,acquire additional 20% stake in Sidwal,company ready to grab mkt share in RAC
China plus 1 unfolding,global MNC enquiring about RAC & components
Amber started export of components to US
Read 16 tweets
10 Dec
@subex concall transcript Q2fy21

Revenue 933 vs 857 mn yoy, growth 9%
Ebidta up 23%, 254 vs 207 mn yoy
PAT 123 vs 63 mn yoy
Capital reduction exercise complete, shares relisted with FV 5
Project delivery delays due to challenges of remote working
#subex #telecom #IOT #nifty
Business front,telcos in Africa,EU tightening their purses,however longterm investment & exploration in 5G,Iot progressing well
IoT security side resumption of business talks stuck post March
Focus on Digital trust,Suresh Chintada new CTO
Digital trust lab to look at new tech like post quantum cryptography, homomorphic encryption, Blockchain

Tech mahindra deal to cooperate in Blockchain,to cover used spaces around digital trust area with our blocking solutions around their platform
@TechMahindraIES
Read 14 tweets
28 Nov
@GranulesIndia earnings call transcript Q2fy21
No longer a 5 product company
22 launched products
PAT growth up 80% H1fy21 compared to H1fy20,due to fast approval of filed ANDAs,rapid scale up production
Ebidta,PAT > Rev growth- better product mix,sales,op efficiency
#Stocks
32 approved ANDAs(6 yet to launch),13 waiting for approval
Expect 1 MUPS tech based ANDA in Q3 or Q4
Construction MUPS block on track,commercialize Q3fy22
High vol MUPS products & APIs next major driver
Q1fy21 recall of $2 mn tabs Metformin 750mg,this Q 1mn reversed into books
Covid expense 19.3 crs in H1fy21
Rev Q1fy20/21 858/700 cr up23% yoy
Gross margin moved 48.6 to 57.9% YoY thru new launches,increased finished dosages,product rationalization in PFI & Finished dosages
PAT 164 vs 96 crs,up 71% yoy
#Stocks #pharma #Nifty #sensex
Read 10 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!